Atropine Sulfate Injection, Solution
Product Images NDC 70518-4188

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 70518-4188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Atropine Sulfate 8mg 20ml(0.4mg mL) 70518 4188 01)

Atropine Sulfate Injection, 0.4 mg/mL (8 mg/20 mL) vial label from RemedyRepack Inc. The label includes storage instructions, package quantity of one vial, and manufacturer information referencing Fresenius Kabi, with directions to see the package insert for use. It also features a barcode and QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Atropine Sulfate Injection, 0.4 mg/mL (8 mg/20 mL) in a 10-vial package. The label indicates it is for multiple doses, to be stored between 20° to 25°C and discarded within 24 hours after opening. It is labeled Rx only, repackaged by RemedyRepack Inc. from Fresenius Kabi, Lake Zurich, IL.*

FDA Label Image

Structure (Atropine Structure)

Chemical structure diagram of Atropine Sulfate, showing its molecular components including a bicyclic tropane ring, ester linkage, phenyl ring, and sulfate and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.